Lot Release Testing Service
Lot Release Testing (LRT) at Creative Biolabs provides rigorous, quality-focused analytical and biological testing services for every batch of your product. We deliver validated custom assays, rapid turnaround times through parallel execution, and comprehensive data packages that assure batch consistency and purity. Clients gain accelerated progression through their research milestones, minimized risk of lot-to-lot variability, and increased confidence in their product's scientific integrity, backed by a partner dedicated to the highest quality standards.
Lot Release Testing: Final Product Quality Assurance
Lot Release Testing (LRT) is the critical final quality control stage, ensuring that every manufactured batch of a drug product meets its predefined specifications. This involves a battery of analytical, biochemical, and biological assays that confirm the identity, purity, safety, and potency of the therapeutic agent. This process is the foundation of quality assurance in biomanufacturing, safeguarding product quality and maintaining high scientific standards. LRT leverages methodologies established during product characterization to provide a final safety net for every commercialized lot.
Contact us to discuss your unique construct - Request a consultation.
What We Can Offer
Creative Biolabs delivers the scientifically rigorous data required to bridge the gap between manufacturing and product qualification. We provide scientifically rigorous data that every production lot - from early research samples to final qualification - is safe, potent, and compliant with all registered specifications.
| Sterility | Identity | Purity | Potency |
|---|---|---|---|
| bacteria or fungal contaminants | SDS-PAGE, Western blot, immunologic assay, or amino acid analysis | HPLC, SDS-PAGE, moisture, endotoxin | In vivo or in vitro test to assess immunogenicity, antigen content, or chemical composition |
How Creative Biolabs' service Can Assist Your Projects
Highlights
Bespoke Assay Validation
We do not rely solely on off-the-shelf tests; we specialize in the custom development and validation of complex potency bioassays specifically tailored to the unique mechanism of action (MoA) of your advanced therapeutic, including antibody drug conjugates (ADCs) and gene therapy vectors.
Global Quality Assurance
Leverage our expertise in major health authorities and the mutual recognition agreement (MRA) to act as your single site for multi-site qualification, drastically simplifying multi-regional distribution.
Accelerated Turnaround
Our controlled facilities utilize parallel testing execution and data flow management to ensure the fastest possible qualification times, minimizing the period between production and final use.
Flawless Technology Transfer
We guarantee the rapid, high-fidelity establishment of your proprietary methods via a controlled technology transfer process, ensuring method equivalence and continuity with minimal downtime.
Don't wait until later stages; early planning minimizes project delays later on - Get a quote today.
Customer Reviews
-
Exceptional Reliability
Using Creative Biolabs' lot release testing in our research has significantly improved the batch-to-batch consistency of our recombinant vector production. The data provided robust evidence of charge variant homogeneity, eliminating an internal QC bottleneck. - J*e R**y. -
Speed and Compliance
Creative Biolabs' agile turnaround times facilitated our rapid pre-clinical product studies. Their detailed assay qualification reports provided all the necessary documentation, contrasting sharply with the slow, high-variability results we saw when attempting to run the LAL assay in-house. - P*t M**n.
FAQs
At what phase of drug development should we establish our lot release testing program?
We strongly recommend establishing your analytical testing plan during pre-clinical and early research development. This allows time for method qualification - determining performance limits - which is necessary for product qualification.
Our product is a novel gene therapy vector. Can Creative Biolabs handle the highly specific Potency and Identity assays required?
Absolutely. Creative Biolabs specializes in advanced modalities. For gene therapy, we utilize specialized qPCR/ddPCR methods for vector genome copy number and perform highly specific DNA sequencing/PCR for identity. Our Potency assays are custom-developed to reflect the specific transduction and expression mechanism of your vector.
How to Contact Us
Creative Biolabs offers industry-leading lot release testing, serving as your strategic partner for high scientific standards and global product qualification. We deliver scientifically precise, timely, and high-integrity data for all biologics, advanced modalities, and traditional therapeutics, backed by two decades of specialist expertise. Please feel free to contact us for more information about our services.
Download our brochure